LSL Pharma Group Inc. (TSXV:LSL)
0.4350
-0.0050 (-1.14%)
At close: Jan 9, 2026
8.75% (1Y)
| Market Cap | 52.73M |
| Revenue (ttm) | 26.80M |
| Net Income (ttm) | 2.78M |
| Shares Out | 121.22M |
| EPS (ttm) | 0.02 |
| PE Ratio | 19.17 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 83,881 |
| Average Volume | 112,908 |
| Open | 0.4400 |
| Previous Close | 0.4400 |
| Day's Range | 0.4350 - 0.4450 |
| 52-Week Range | 0.2900 - 0.5300 |
| Beta | -0.22 |
| RSI | 71.89 |
| Earnings Date | Feb 27, 2026 |